MiraVista Diagnostics’ dedication to innovation and improved accessibility to high quality fungal diagnostics has created a CE marked Histoplasma Urine Antigen LFA.
MiraVista Diagnostics is leading the industry with a new Histoplasma Urine Antigen LFA. The rapid, non-invasive test has a proven clinical sensitivity of 93.18% and 96.97% specificity relative to culture proven cases, can be operated in low complexity clinical settings and requires no additional equipment.
